Login to Your Account

Pfizer Buys More, Gains Caspase Inhibitors Through Idun Purchase

By Karen Pihl-Carey

Friday, February 25, 2005
Although it had plenty of money in the bank, Idun Pharmaceuticals Inc. made a strategic decision to become part of a big pharmaceutical company that will help advance its lead liver disease product. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription